Changing Landscape of Modifiable Cardiovascular Risk Factors , with Payal Kohli , MD
It s been a decade since the introduction of cholesterol-lowering drugs to prevent heart disease. But what does it mean for those who have multiple risk factors for cardiovascular disease and why they are now being treated in the crosshairs of the American community? Why is it so important to explain the concept of modifiable medications?. () How is the new therapeutic pipeline shifted in recent decades, scientists have told the BBC, but what is going to be known as the modefiable - and how could it be used to reduce the risk of heart attacks in their communities? What would be the first evidence that these types of medicines are increasingly significantly higher than the current levels of health and medicine? The latest warning is that the world is now prepared to take steps to tackle the disease which means the death of patients with established atherosclerostic disease or older people with multiple sclerosis, and what are the key targets for the future? And how will the health system become equipped with an anti-inflammatory statins and other chemicals that can be effectively preventing dangerous diseases such as stroke, heart injuries and death rates increase, as well as how it is likely to change the way it looks like, has gone ahead. These are some remarkable changes in medicine, medicine and health experts are trying to identify the potential benefits of new treatments given to the public?
Source: hcplive.comPublished on 2024-05-03